Key HighlightsMotixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease and beta-thalassemia enabling accelerated access to gene therapies73% ...
A report that was jointly produced by the Canadian Centre for Policy Alternatives and the Parkland Institute finds Alberta's ...
Key HighlightsMotixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease and beta-thalassemia enabling accelerated access to gene therapies73% ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果